Circulating gastrin concentrations in patients at increased risk of developing colorectal carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 3, 2014, Pages 480-486

  Paterson, Adrienne C ^a   Macrae, Finlay A ^b   Pizzey, Cathy ^b   Baldwin, Graham S ^a   Shulkes, Arthur ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Department of Gastroenterology Melbourne Health ^*  (Australia)

Author keywords

Gastrin; Gastrointestinal tract; Processing

Indexed keywords

AMIDE; GASTRIN; GASTRIN AMIDE; GASTRIN GLYCINE; GLYCINE; PROGASTRIN; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; FAMILIAL COLON POLYPOSIS; FAMILY HISTORY; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADENOMATOUS POLYPOSIS COLI; ADULT; COLORECTAL NEOPLASMS; FEMALE; GASTRINS; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; RISK; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 84897614323     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12417     Document Type: Article

References (45)

1. Winawer S, Fletcher R, Rex D etal. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003; 124: 544-560.
2. Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 2000; 119: 854-865.
3. Voskuil DW, Vasen HF, Kampman E etal. Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. National Collaborative Group on HNPCC. Int. J. Cancer 1997; 72: 205-209.
4. St John DJ, McDermott FT, Hopper JL etal. Cancer risk in relatives of patients with common colorectal cancer. Ann. Intern. Med. 1993; 118: 785-790.
5. Aly A, Shulkes A, Baldwin GS. Gastrins, cholecystokinins and gastrointestinal cancer. Biochim. Biophys. Acta 2004; 1704: 1-10.
6. Smith AM, Watson SA. Review article: gastrin and colorectal cancer. Aliment. Pharmacol. Ther. 2000; 14: 1231-1247.
7. Dockray GJ. Gastrin, growth, and colon neoplasia. Gut 2000; 47: 747-748.
8. Ferrand A, Wang TC. Gastrin and cancer: a review. Cancer Lett. 2006; 238: 15-29.
9. Dockray GJ, Varro A, Dimaline R etal. The gastrins: their production and biological activities. Annu. Rev. Physiol. 2001; 63: 119-139.
10. Nemeth J, Taylor B, Pauwels S etal. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 1993; 34: 90-95.
11. Ciccotosto GD, McLeish A, Hardy KJ etal. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995; 109: 1142-1153.
12. Van Solinge WW, Nielsen FC, Friis-Hansen L etal. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993; 104: 1099-1107.
13. Siddheshwar RK, Gray JC, Kelly SB. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut 2001; 48: 47-52.
14. Hollande F, Imdahl A, Mantamadiotis T etal. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology 1997; 113: 1576-1588.
15. Baldwin GS, Hollande F, Yang Z etal. Biologically active recombinant human progastrin(6-80) contains a tightly bound calcium ion. J. Biol. Chem. 2001; 276: 7791-7796.
16. Wang TC, Koh TJ, Varro A etal. Processing and proliferative effects of human progastrin in transgenic mice. J. Clin. Invest. 1996; 98: 1918-1929.
17. Koh TJ, Dockray GJ, Varro A etal. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J. Clin. Invest. 1999; 103: 1119-1126.
18. Aly A, Shulkes A, Baldwin GS. Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa. Int. J. Cancer 2001; 94: 307-313.
19. Singh P, Velasco M, Given R etal. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. Gastroenterology 2000; 119: 162-171.
20. Smith AM, Watson SA. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut 2000; 47: 820-824.
21. Do C, Bertrand C, Palasse J etal. A new biomarker that predicts colonic neoplasia outcome in patients with hyperplastic colonic polyps. Cancer Prev. Res. (Phila) 2012; 5: 675-684.
22. Koh TJ, Bulitta CJ, Fleming JV etal. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J. Clin. Invest. 2000; 106: 533-539.
23. Nakata H, Wang SL, Chung DC etal. Oncogenic ras induces gastrin gene expression in colon cancer. Gastroenterology 1998; 115: 1144-1153.
24. Thorburn CM, Friedman GD, Dickinson CJ etal. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998; 115: 275-280.
25. Vasen HF, Watson P, Mecklin JP etal. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456.
26. Bardram L, Rehfeld JF. Production and evaluation of monospecific antibodies for a processing-independent sequence of human progastrin. Scand. J. Clin. Lab. Invest. 1989; 49: 173-182.
27. Hilsted L, Rehfeld JF. Measurement of precursors for alpha-amidated hormones by radioimmunoassay of glycine-extended peptides after trypsin-carboxypeptidase B cleavage. Anal. Biochem. 1986; 152: 119-126.
28. Kalbfleish JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley and Sons, 1980.
29. Peach HG, Barnett NE. Determinants of basal plasma gastrin levels in the general population. J. Gastroenterol. Hepatol. 2000; 15: 1267-1271.
30. Grabowska AM, Watson SA. Role of gastrin peptides in carcinogenesis. Cancer Lett. 2007; 257: 1-15.
31. Worthley DL, Whitehall VL, Spring KJ etal. Colorectal carcinogenesis: road maps to cancer. World J. Gastroenterol. 2007; 13: 3784-3791.
32. Robertson DJ, Larsson H, Friis S etal. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 2007; 133: 755-760.
33. van Soest EM, van Rossum LG, Dieleman JP etal. Proton pump inhibitors and the risk of colorectal cancer. Am. J. Gastroenterol. 2008; 103: 966-973.
34. Yang YX, Hennessy S, Propert K etal. Chronic proton pump inhibitor therapy and the risk of colorectal cancer. Gastroenterology 2007; 133: 748-754.
35. Renga M, Brandi G, Paganelli GM etal. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut 1997; 41: 330-332.
36. Talley NJ, Chute CG, Larson DE etal. Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann. Intern. Med. 1989; 111: 738-742.
37. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170.
38. Konishi M, Kikuchi-Yanoshita R, Tanaka K etal. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996; 111: 307-317.
39. Smyrk TC, Lynch HT. Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur. J. Cancer 1999; 35: 171-172.
40. Svendsen LB, Bisgard ML, Gustafsen J etal. Serum gastrin values in patients with familial adenomatous polyposis. Dis. Colon Rectum 1994; 37: 22-25.
41. Mihas AA, Maliakkal RJ, Shueke M etal. Serum gastrin levels in patients with colorectal cancer and adenomatous polyps: a prospective study. Res. Commun. Mol. Pathol. Pharmacol. 1995; 90: 301-304.
42. Seitz JF, Giovannini M, Gouvernet J etal. Elevated serum gastrin levels in patients with colorectal neoplasia. J. Clin. Gastroenterol. 1991; 13: 541-545.
43. Lamberts R, Wartenberg T, Creutzfeldt W. Role of circulating gastrin in colorectal adenomas and carcinomas. Digestion 1999; 60: 101-109.
44. Suzuki H, Matsumoto K, Terashima H. Serum levels of gastrin in patients with colorectal neoplasia. Dis. Colon Rectum 1988; 31: 716-717.
45. Konturek PC, Bielanski W, Konturek SJ etal. Progastrin and cyclooxygenase-2 in colorectal cancer. Dig. Dis. Sci. 2002; 47: 1984-1991.